4 years ago

fool.com.au

Broker initiates a buy rating for Openpay, but can it rival Afterpay?

4 years ago

proactiveinvestors.com.au

Imugene granted HER-Vaxx immunotherapy patent in the US; shares rise 12%

4 years ago

finnewsnetwork.com.au

Imugene (ASX:IMU) receives US patent approval for HER-VAxx

4 years ago

smallcaps.com.au

5G Networks posts record quarterly cashflow, signs first indirect channel agreement

4 years ago

stockhead.com.au

Tech: 5GN gets another boost in the wake of strong Q4 cash flow numbers

4 years ago

fool.com.au

2 top ASX 20 shares to buy for income and growth

4 years ago

themarketherald.com.au

Imugene (ASX:IMU) receives U.S. Patent for its cancer immunotherapy

4 years ago

stockhead.com.au

Corporate: Womens fashion retailer Mosaic Brands is the latest to drop from a negative trading update

4 years ago

smallcaps.com.au

Oklo Resources’ gold discoveries at west Mali project continue

4 years ago

smallcaps.com.au

Imugene granted HER-Vaxx immunotherapy patent in the United States